Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone (Q57003412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Marco Filicori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Graciela E Cognigni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Patrizia Pocognoli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Cristina Tabarelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Federica Ferlini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Tiziana Perri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Lodovico Parmegiani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

390-397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

From HMG through purified urinary FSH preparations to recombinant FSH: a substitution study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Accumulation of human chorionic gonadotrophin in the serum of patients during in-vitro fertilization treatment cycles with Pergonal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

A dose proportionality study of subcutaneously and intramuscularly administered recombinant human follicle-stimulating hormone (Follistim*/Puregon) in healthy female volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Assessment of bioequivalence after subcutaneous and intramuscular administration of urinary gonadotrophins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Biological characterization of recombinant human follicle stimulating hormone isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

"Coasting" does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

The Role of Gonadotropins in the Selection of the Preovulatory Follicle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Stimulation and growth of antral ovarian follicles by selective LH activity administration in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Clinical review 126: Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Intracytoplasmic sperm injection pregnancy after low-dose human chorionic gonadotropin alone to support ovarian folliculogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

Use of luteinizing hormone in the treatment of infertility: time for reassessment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2900594-6

10.1016/S0015-0282(03)00594-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12909504%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference